-
About US
About US
- Patients
-
Professional Medical Solutions
Professional Medical Solutions
- News
- Investor Relations
AcoArt Canna®
Coronary Sirolimus DCBCoronary Sirolimus DCB
· Superior therapeutic effect has been established versus comparable paclitaxel-coated products
· Enhance drug retention in tissues
· Lipophilic excipient matrix +Sirolimus, improving drug transfer rate with optimization
| Name | AcoArt Canna |
| Drug | Sirolimus |
| Excipient | Magnesium stearate (lipophilic) |
| Diameter(mm) | 2.00/2.25/2.50/2.75/3.00/3.25/3.50/3.75/4.00 |
| Length(mm) | 10/15/20/25/30/35/40 |
| Guidewire(inch) | 0.014 |
|
Matching Guide Cathete(F) |
≥5 |
| RBP(Bar) | 12 |
Copyright © 2023 先瑞达医疗科技控股有限公司 京ICP备19054161号-3 MINETHINK